About us  

Patient-centered biomedicine

Coremine Vitae is a biomedical company that prioritizes patient-centred care.  We work to develop solutions that makes the latest scientific knowledge accessible to the individual patient and their healthcare provider.

Our team has a broad background in science and research, with expertise in molecular biology, biomedicine, toxicology and cancer research.

Mission

Coremine Vitae mission is to provide patients with comprehensive, tailored information about their treatment options, enabling informed choices and collaborative decision-making with their healthcare providers.

Vision

Our vision is to empower patients with personalized information, fostering knowledge and facilitating shared decision-making with their doctors.

Our Values

Integrity

We are committed to upholding high standards of ethics, transparency, and trustworthiness in all our operations. This includes ensuring that all patient information is managed with the utmost privacy and security.

Quality

We strive to deliver high quality in all aspects of our work, from research and analysis to patient support.

Compassion

Empathy and understanding are central to our mission. In all our interactions, we strive to ensure that patients and their families feel supported and cared for.

Empowerment

We want patients and their families to be equipped with the knowledge and resources needed to make informed decisions about their health care.

COREMINE VITAE TEAM

Chief Executive Officer

CSO, Head of Scientific Team and Senior Scientist

Analyst Scientist

UX and Service Designer

Our Collaborators

We are actively engaged in numerous research projects in collaboration with leading medical research institutions across Norway and Europe. Coremine Vitae collaborates with PubGene AS on the research project "Coremine Vitae - Identifying Personalized Treatment Options for Cancer Patients", in partnership with Haukeland University Hospital.  

The research project, funded by the Research Council of Norway, focuses on both the development of analytical tools and the implementation of Coremine Vitae for generating treatment-relevant information for patients. Additionally, we collaborate closely with PubGene AS and Vitae Evidence AS, leveraging their expertise in bioinformatics and tool support to enhance our analytical capabilities. Coremine Vitae collaborates with several other key partners, including Moloklinikken (private clinic), where we deliver personalized medicine reports tailored to the needs of their patients. Additionally, we maintain an active role in CellMover's (biotechnology company) research projects, contributing our expertise and providing them with essential data to advance their initiatives. These collaborations exemplify our commitment to enhancing precision medicine through strategic partnerships and the integration of cutting-edge research.
Integration icon

BRAIN CANCER ASSOCIATION COLLABORATION

In the past years, Coremine Vitae has collaborated closely with the Norwegian Brain Cancer Association, providing personalized reports to several of its association's members. In addition, we are collaborating on ‘The Brain Cancer Portal’ project, funded by the DAM-Health Foundation.

This web-based platform is designed to disseminate essential information and insights on various brain diagnoses, encompassing, among others, medical news, breakthrough treatments, and clinical trials.
Coremine Vitae logoLogo
Empowering patients with knowledge about their treatment options,. Coremine Vitae strives to provide patients with personalized information about their diagnosis.
Contact
Coremine Vitae AS
Klaus Torgårds vei 3, 0372
Oslo, Norway.
E-post: contact@coreminevitae.com